The Roskamp Institute, jointly with The Open University UK, offers a doctoral degree in Neuroscience and is pleased to announce the program’s 14th graduate Charis Ringland. Charis joined the Institute as a Ph.D. student in January 2017. While she worked on a number of projects throughout her time at the Institute, her research primarily investigated the role of apolipoprotein E (apoE) in the development of Alzheimer’s disease. Owing to Covid-19, this was our first ever virtual viva voce examination, conducted on GoToMeeting with participants from Sarasota, Germany, and the two examiners in North Carolina and the UK..
Charis began her studies in neuroscience at the University of Leeds, UK, where she earned her bachelor’s degree. She continued her studies and gained practical experience during her master’s course at Imperial College London. Her interest in neurodegenerative disorders stemmed from these studies and led Charis to pursue a Ph.D. in Neuroscience at the Roskamp Institute. “I am grateful to have had the opportunity to conduct my Ph.D. at the Roskamp Institute. I enjoyed contributing to the understanding of neurodegenerative disorders through my Ph.D. research and hope to continue doing so in the future.” Charis’ research into the MMP-9 enzyme and its interaction with apoE in Alzheimer’s disease, which constituted much of her Ph.D. research, was recently published in the journal Neurobiology of Aging.
Charis currently lives in Germany with her husband Jonas Schweig, who received his Ph.D. at the Institute in 2018. She has been a valuable member of the Roskamp Institute research group and she will be greatly missed. Congratulations Charis!
Publication: Neurobiology of Aging, Volume 95 In progress November 2020
“Apolipoprotein E isoforms differentially regulate matrix metallopeptidase 9 function in Alzheimer’s disease” Link: Article Link
For more information on the Roskamp Institute Ph.D. Program, click here